Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2001
08/16/2001WO2001010380A3 Benzanilides as potassium channel openers
08/16/2001WO2001009119A3 Chemokine receptor antagonists
08/16/2001WO2001008688A3 Beta-carboline drug products
08/16/2001WO2000056302A3 Vanadium (iv) complexes containing catacholate ligand and having spermicidal activity
08/16/2001US20010014684 Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
08/16/2001US20010014452 For the fluorometric detection of complementary DNA fragments; water soluble
08/16/2001EP1123297A1 New compounds, their preparation and use
08/16/2001EP1123293A1 Core-extended perylene bisimides
08/16/2001EP1123292A1 New compounds, their preparation and use
08/16/2001EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation
08/16/2001EP1123279A1 New compounds, their preparation and use
08/16/2001EP1123277A1 Epibatidine analogues as acetylcholine receptor antagonists
08/16/2001EP0828715B1 N-oxides as antibacterial agents
08/16/2001EP0677050B1 Novel pyridone carboxylic acid derivatives
08/16/2001DE10006297A1 Substituierte Benzimidazole Substituted benzimidazoles
08/16/2001CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
08/16/2001CA2399136A1 1h-imidazopyridine derivatives
08/15/2001CN1308632A 'Beta'-carboline compound
08/15/2001CN1308631A Heterocyclic derivatives which inhibit factor xa
08/15/2001CN1308622A Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
08/15/2001CN1308617A Antiviral macrocyclic compounds
08/15/2001CN1308614A Benzimidazoles, production thereof and use thereof medicaments
08/15/2001CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
08/15/2001CN1308056A Heterocyclic benzonitrile
08/15/2001CN1069643C Naphthyridine derivatives and their analogues inhibiting cytomegalovirus
08/14/2001US6274806 Dye sensitized electrode of a substrate with electrical conductive surface, an oxide semiconductor film formed on it, which supports a platinum complex
08/14/2001US6274738 Carboxamide derivatives having aryl and thiazole rings
08/14/2001US6274728 Esterified dye
08/14/2001US6274536 Pyrazole derivatives as herbicides
08/14/2001CA2226406C Novel pyridone carboxylic acid derivatives
08/14/2001CA2148380C 5-arylindole derivatives
08/09/2001WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
08/09/2001WO2001057040A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
08/09/2001WO2001057039A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
08/09/2001WO2001057038A1 Heterocyclic compounds and their use as parp inhibitors
08/09/2001WO2001057022A2 Pyrazole compositions useful as inhibitors of erk
08/09/2001WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
08/09/2001WO2001056993A2 Pyrazole compositions useful as inhibitors of erk
08/09/2001WO2001056607A1 Integrin expression inhibitors
08/09/2001WO2001019788A3 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
08/09/2001WO2001014376A8 Novel spiro compounds
08/09/2001US20010012905 From 4-acetylnaphthalic anhydride; reacting with phenyl hydrazine while heating in a solvent
08/09/2001US20010012895 Therapy for hair loss in mammals; drug resistance; nervous system disorders
08/09/2001DE10005280A1 Partikuläre Zusammensetzung, Verfahren zu ihrer Herstellung und deren Verwendung Particulate composition, process for their preparation and their use
08/09/2001CA2399545A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
08/09/2001CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
08/09/2001CA2369076A1 Pyrazole compositions useful as inhibitors of erk
08/08/2001EP1122257A1 Benzimidazole compounds as ORL1-receptor agonists
08/08/2001EP1122256A1 Method of stabilizing aqueous pyrazoloacridone derivative solution
08/08/2001EP1122254A2 4-Sulfonamide piperidine derivatives, method for their preparation and phamaceutical compositions containing them
08/08/2001EP1121363A2 6-SUBSTITUTED PYRAZOLO 3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
08/08/2001EP1121359A1 Imidazo-isoquinoline compounds, their compositions and uses
08/08/2001EP1121355A1 Quinoline derivatives and their use as antibacterial agents
08/08/2001EP0625155B1 Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
08/08/2001CN1307580A Syntheses of variety of lamellarin compounds and analogues
08/08/2001CN1307577A Imidazo pyridine derivatives which inhibit gastric acid secretion
08/08/2001CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/08/2001CN1069318C Cyclic gmp-specific phosphodiesterase inhibitors
08/08/2001CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase
08/08/2001CN1069314C 2-oxoindoline derivative
08/08/2001CN1069309C N-(aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application thereof
08/07/2001US6271380 1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
08/07/2001US6271375 Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes
08/07/2001US6271253 Cyclooxygenase inhibitors
08/07/2001US6271251 Cardiovascular disorders
08/07/2001US6271241 Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors
08/07/2001US6271235 HIV protease inhibitors
08/07/2001US6271231 Pharmaceutically active compounds
08/07/2001US6271229 Method of treating gastrointestinal motility disorders
08/07/2001US6271195 Aminimide-containing molecules and materials as molecular recognition agents
08/07/2001CA2104782C 1-substituted, 2-substituted 1h-imidazo-[4,5-c]quinolin-4- amines
08/02/2001WO2001055719A2 Diagnostic kit for detecting creatine levels
08/02/2001WO2001055150A1 4-heteroaryl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
08/02/2001WO2001055148A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
08/02/2001WO2001055147A1 PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
08/02/2001WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
08/02/2001WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/02/2001WO2001055110A1 Isatine derivatives with neurotrophic activity
08/02/2001WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
08/02/2001US20010011134 Cyclic and heterocyclic N-substituted alpha-iminohydroxamic and -carboxylic acids
08/02/2001US20010011133 Cognition activators; psychological disorders
08/02/2001US20010011093 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
08/02/2001US20010011092 High affinity ligands for nociceptin receptor ORL-1
08/02/2001DE10004157A1 New pyridyl- or pyrimidinyl-substituted bicyclic pyrrole derivatives, are cyclokine release inhibitors useful for treating immune system-related disorders, e.g. cancer, multiple sclerosis or arthritis
08/02/2001CA2396596A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
08/02/2001CA2394525A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
08/02/2001CA2394292A1 Isatine derivatives with neurotrophic activity
08/01/2001EP1120416A1 Pyrido[2.3-b][1,4]benzodiazepinones as M2 receptor ligand for the treatment of neurological disorders
08/01/2001EP1120414A1 Disubstituted maleimide compounds and medicinal utilization thereof
08/01/2001EP1119563A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/01/2001EP1119562A1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/01/2001EP1119550A1 2-substituted heterocyclic sulfonamides
08/01/2001EP1119548A1 Pyrrole-2,5-diones as gsk-3 inhibitors
08/01/2001EP1119354A1 Peripherally acting anti-pruritic opiates
08/01/2001CN1306533A Imidazo pyridine derivatives which inhibit gastric acid secretion
08/01/2001CN1306532A Novel pyrrolo-(3,4-B) quinoline derivatives, method for prodn. and use thereof as medicament
08/01/2001CN1306524A Fluorophenyl resin compounds
08/01/2001CN1306510A Optical active tetrahydrobenzindole derivatives
07/2001
07/31/2001US6268505 2-(2′Hydroxyphenyl) benzotriazoles and process for their preparation
07/31/2001US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases